On June 13, 2024, Chairman and actual controller Miao Yongjun of Autobio Diagnostics increased the company's shares by 8,000 through the Shanghai Stock Exchange system with centralized bidding trading method, accounting for 0.0014% of the company's total share capital. The total transaction amount of this increase was RMB 381,700. Miao Yongjun plans to increase the company's shareholding by using his own funds through the Shanghai Stock Exchange system with centralized bidding trading method within the six months from the first increase (June 13, 2024), and the amount of the planned additional shares will not be less than RMB 20 million and not more than RMB 40 million (including the amount of shares already increased in this time).
安图生物：董事长、实控人苗拥军拟继续增持2000万元-4000万元
Autobio Diagnostics: Chairman and actual controller Miao Yongjun plans to continue to increase shareholding by RMB 20-40 million.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.